FGIPX
Price
$16.16
Change
+$0.10 (+0.62%)
Updated
Jul 25 closing price
Net Assets
1.48B
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

FGIPX vs RMFEX

Header iconFGIPX vs RMFEX Comparison
Open Charts FGIPX vs RMFEXBanner chart's image
Macquarie Growth and Income Instl
Price$16.16
Change+$0.10 (+0.62%)
VolumeN/A
Net Assets1.48B
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
FGIPX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FGIPX vs. RMFEX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGIPX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. FGIPX (1.48B). FGIPX pays higher dividends than RMFEX: FGIPX (2.10) vs RMFEX (1.53). FGIPX was incepted earlier than RMFEX: FGIPX (12 years) vs RMFEX (23 years). FGIPX (0.77) is less costly to investors than RMFEX (0.62). FGIPX is a more actively managed with annual turnover of: 35.00 vs. RMFEX (31.00). FGIPX has a lower initial minimum investment than RMFEX: FGIPX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. FGIPX (6.35). RMFEX return over 5 years is better than : 62.99 vs. FGIPX (46.83).
FGIPXRMFEXFGIPX / RMFEX
Total Expense Ratio0.770.62124%
Annual Report Gross Expense Ratio0.770.62124%
Fund Existence12 years23 years-
Gain YTD12.46711.527108%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B111B1%
Annual Yield % from dividends2.101.53137%
Returns for 1 year6.3511.7454%
Returns for 3 years30.9132.0896%
Returns for 5 years46.8362.9974%
Returns for 10 years-15.0588.96-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited